Synthesis of GD3-lactam: a potential ligand for the development of an anti-melanoma vaccine.

Nafizal Hossain, Amparo Zapata, Mikael Wilstermann, Ulf Nilsson, Göran Magnusson

Research output: Contribution to journalArticlepeer-review

13 Citations (SciVal)


The novel sialyl donor methyl (ethyl 4,7,8,9-tetra-O-acetyl-5-N,N-diacetylamino-3,5-dideoxy-2-thio-3-thiophenyl-D-erythro-beta-L-gluco-non-2-ulopyranosid)onate was used for glycosylation of a lactosyl acceptor to give the GM3-trisaccharide derivative in 83% yield. Introduction of an azido group at C-9" of the GM3-trisaccharide derivative, transformation into a glycosyl acceptor, and sialylation with the above mentioned novel sialyl donor gave a GD3-trisaccharide in 50% yield. Reduction of the azido group gave the corresponding amine, which underwent spontaneous lactamization to the GD3-[1"'-9"]-lactam in an overall yield of 86%. Removal of protecting groups of over five steps, followed by per-O-acetylation gave an acetylated GD3-[1"'-9"]-lactam TMSEt glycoside in 27% overall yield. The acetylated GD3-[1"'-9"]-lactam TMSEt glycoside is suitable for glycosylation of linker-arms and the resulting linker-glycosides are planned to be coupled to carrier proteins, thus providing immunogens for trial vaccinations against malignant melanoma.
Original languageEnglish
Pages (from-to)569-580
JournalCarbohydrate Research
Issue number7
Publication statusPublished - 2002

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Organic chemistry (S/LTH) (011001240)

Subject classification (UKÄ)

  • Organic Chemistry


  • Melanoma
  • Antigen
  • GD3
  • GD3-lactam
  • Glycosylation


Dive into the research topics of 'Synthesis of GD3-lactam: a potential ligand for the development of an anti-melanoma vaccine.'. Together they form a unique fingerprint.

Cite this